Deep Tech Startups

Measurlabs provides accredited laboratory testing services for R&D, quality control, and regulatory compliance across polymers, packaging, food, medical devices, pharmaceuticals, semiconductors, and construction materials. The company serves over 1,000 customers globally through ISO 17025-accredited testing facilities and centralized sample hubs in Helsinki, Cambridge, and Palo Alto.

1 investor

Mecanum manufactures acoustic material characterization instruments and offers consulting services in noise and vibration control for building, transportation, and material acoustics. The company also develops custom vibroacoustic characterization and simulation software.

1 investor

Mechanize builds simulated environments and evaluation benchmarks for training and testing frontier coding agents on software engineering tasks such as building features, deploying applications, and debugging code. The company uses these environments as reinforcement learning signals, with a long-term aim of automating knowledge work across the economy.

1 investor

Mecorad automates inline interventions in steel and metals manufacturing to reduce energy consumption and material losses, addressing emissions from industrial production.

1 investor

Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.

1 investor

Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development. The company focuses on discovering genetic features of cancer with translational relevance for stratifying patients and finding novel drug targets.

1 investor

Medicinal Genomics provides microbial and plant testing solutions for the cannabis, nutraceutical, and food safety industries through validated qPCR assays and automated liquid handling platforms. Their offerings enable rapid pathogen detection and species identification with turnaround times measured in hours rather than days.

1 investor

Meep develops biological monitoring technology to enable frequent clinical-grade testing for chronic disease patients, reducing unnecessary hospitalizations and intensive care admissions.

1 investor

Melior Discovery provides in vivo pharmacology services and phenotypic screening platforms for pharmaceutical and biopharmaceutical companies to evaluate candidate therapeutics in animal disease models. The company operates proprietary technology including theraTRACE® to identify new therapeutic potential and support drug development and repositioning.

1 investor

Melt Interface Technologies (formerly Diver-X) develops human-machine interface hardware, including input devices, tracking, and haptics technology such as its ContactGlove product, spanning consumer input devices, industrial interfaces for XR/robotics/teleoperation, and custom co-development solutions. The company serves both everyday users and enterprise manufacturing clients, and is based in Tokyo, Japan.

1 investor

MELTIN develops cyborg technology by integrating robotics, artificial intelligence, and medical engineering to create medical devices and solutions. The company serves the medical device and healthcare sectors globally.

1 investor

MemComputing develops semiconductor chips and software based on a patented memcomputing computing paradigm for optimization, AI, and high-performance computing applications. The company offers both chip designs (MEMAI, MEMGPU, MEM5G, MEMCPU) and the MEMCPU Platform, serving customers in aerospace, energy, ports, and defense.

1 investor

MemPro produces high-surface-area metal oxides embedded on nanofibers for use in energy harvesting and storage, filtration, sensors, electronics, and pharmaceutical/chemical catalysis applications. The technology reduces the cost of metal oxide deployment through increased surface area.

1 investor

Mentor provides digital twin technology for the semiconductor and electronic systems industry to navigate complexity, geopolitical volatility, and cost pressures through software-defined and AI-powered solutions.

1 investor

Merlin Mobility develops autonomous driving technology aimed at reducing vehicular collisions and enabling safe driving for teenagers and adults.

1 investor

Meshmerize develops dynamic mesh networking software that enables reliable wireless connectivity for mining operations in underground and surface sites, adapting to physical obstructions and remote locations without traditional infrastructure.

1 investor

Mesh Optical Technologies designs and manufactures optical systems at scale, operating its own factories and building the hardware and software behind them. Its focus is advancing optical manufacturing to address a supply chain gap in hyperscale computing and to build optical hardware for terrestrial and space applications.

1 investor

MESON develops spatial intelligence technology combining AR, VR, and AI to create new perspectives and shared experiences. The company works with various enterprises to build products that expand how people perceive and understand reality.

1 investor

Mesosil develops nanomaterial platform technology for dental materials and other applications, focusing on host-biomaterial interactions and infection prevention. The company was founded based on over a decade of nanotechnology research from its founder's doctoral work.

1 investor

Meta-Flux builds in silico simulation software that models disease biology — cellular state, perturbation response, and therapeutic intervention — using mechanistic models grounded in public reference atlases and proprietary multi-omic data from partner biobanks. The platform targets drug discovery in neurodegeneration (Parkinson's, Alzheimer's, ALS, MSA) and immuno-oncology (breast, lung, melanoma, colorectal) to improve target selection and patient stratification.

1 investor

Metalchemy provides scientific testing services including stability, compatibility, and performance evaluation for products, formulations, and materials across beauty and personal care, food packaging, healthcare, fashion, textiles, and agriculture sectors.

1 investor

metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.

1 investor

Metalenx develops metalens (metasurface optics) technology and products, including offerings for automotive electronics (METAELEC) and industrial inspection thermal imaging (Thermometa). The company provides custom optical solutions from requirement consultation through design, sampling, testing, and delivery.

1 investor

MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections. Its lead KLS-1 series targets complicated infections while its KLS-2 series is tuned for antimicrobial coatings on medical equipment such as catheters and joint implants.

1 investor